Video

Dr. Thomas Powles explains standard treatment for metastatic urothelial cancer

Treatment following progression on chemotherapy and an immune checkpoint inhibitor remains an unmet medical need.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Thomas Powles, MBBS, MRCP, MD, director, Barts Cancer Institute, discusses standard treatment for patients with metastatic urothelial cancer in the frontline setting and beyond.

      Newsletter

      Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

      © 2025 MJH Life Sciences

      All rights reserved.